Tianda Pharmaceuticals Limited (HKG:0455)
Hong Kong · Delayed Price · Currency is HKD 0.1040
0.00 (0.00%)
Jul 30, 2026, 11:15 AM HKT
Tianda Pharmaceuticals Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Mar '22 Mar 31, 2022 |
| 224 | 277 | 363 | 469 | 871 | 501 | |
Market Cap Growth | -40.57% | -23.67% | -22.48% | -46.17% | 73.82% | 15.35% |
Enterprise Value | 285 | 314 | 358 | 380 | 787 | 493 |
Last Close Price | 0.10 | 0.13 | 0.17 | 0.21 | 0.39 | 0.21 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Mar '22 Mar 31, 2022 |
Forward PE | - | 6.55 | 6.55 | 6.55 | 6.55 | 6.55 |
PS Ratio | 0.69 | 0.86 | 1.10 | 0.88 | 1.59 | 0.98 |
PB Ratio | 0.49 | 0.61 | 0.72 | 0.79 | 1.33 | 0.64 |
P/TBV Ratio | 0.64 | 0.79 | 0.94 | 0.95 | 1.64 | 0.79 |
P/FCF Ratio | 31.15 | 38.63 | - | - | 12.69 | - |
P/OCF Ratio | 15.93 | 19.76 | - | - | 8.55 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 0.88 | 0.97 | 1.09 | 0.71 | 1.44 | 0.97 |
EV/FCF Ratio | 39.64 | 43.76 | - | - | 11.47 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.29 | 0.29 | 0.25 | 0.19 | 0.22 | 0.20 |
Debt / EBITDA Ratio | - | - | - | 20.85 | - | - |
Debt / FCF Ratio | 18.48 | 18.48 | - | - | 2.06 | - |
Net Debt / Equity Ratio | 0.13 | 0.13 | 0.07 | -0.10 | -0.34 | -0.24 |
Net Debt / EBITDA Ratio | -2.63 | -2.63 | -1.46 | 60.10 | 8.04 | 6.46 |
Net Debt / FCF Ratio | 8.53 | 8.53 | -1.17 | 0.58 | -3.27 | 3.09 |
Asset Turnover | 0.43 | 0.43 | 0.39 | 0.53 | - | 0.44 |
Inventory Turnover | 4.47 | 4.47 | 3.38 | 4.88 | - | 3.86 |
Quick Ratio | 0.63 | 0.63 | 0.69 | 0.89 | 1.40 | 1.83 |
Current Ratio | 0.83 | 0.83 | 0.86 | 1.10 | 1.54 | 2.13 |
Return on Equity (ROE) | -14.61% | -14.61% | -11.19% | -4.01% | - | -2.74% |
Return on Assets (ROA) | -4.47% | -4.47% | -4.02% | -1.81% | - | -2.40% |
Return on Invested Capital (ROIC) | -10.45% | -10.22% | -10.06% | -6.02% | -13.65% | -6.81% |
Return on Capital Employed (ROCE) | -10.60% | -10.60% | -10.50% | -4.80% | -9.70% | -4.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Mar '22 Mar 31, 2022 |
Earnings Yield | -31.30% | -25.24% | -16.89% | -5.15% | -6.27% | -3.95% |
FCF Yield | 3.21% | 2.59% | -8.34% | -21.13% | 7.88% | -12.37% |
Dividend Yield | - | - | - | 1.22% | 0.89% | 1.21% |
Total Shareholder Return | - | - | - | 1.22% | 0.89% | 1.21% |